Tracon Pharmaceuticals Secures $16,500,002 New Round

  • Feed Type
  • Date
    4/1/2011
  • Company Name
    Tracon Pharmaceuticals
  • Mailing Address
    8910 University Center Dr. San Diego, CA 92122
  • Company Description
    TRACON Pharmaceuticals, Inc. is a fast growing biotechnology company developing next-generation targeted therapies for cancer and related diseases. We are addressing unmet needs in this arena with product candidates that focus on cellular targets specifically implicated in cancer growth and angiogenesis.
  • Website
    http://www.traconpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $16,500,002
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount sold includes cash proceeds and conversion of $2,500,000 of principal/interest under certain promissory notes into equity at the purchase price paid by cash investors. Another ~$8 million in cash may be invested at the option of certain investors. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.